2-(4-(Benzyloxy)-3,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 250mg

2-(4-Biphenylyl)indole>98.0%(GC)5g

2,2,3,4,4,4-Hexafluorobutyl acrylate, 90.0%, 1g

4-Bromo-5-fluoro-2-methylbenzonitrile, 95.0%, 10g

Decyltrimethylammonium Bromide>99.0%(T)25g

ethyl (2-amino-4-methyl-1,3-thiazol-5-yl)acetate, 95.0%, 250mg

7-chloro-2-(chloromethyl)quinazolin-4(3H)-one, 95.0%, 2.5g

Naringin, min. 98%, 100 g, plastic packaging.

(3aS,4S,6R,6aR)-6-(6-Amino-2-chloro-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxole-4-carboxylic acid, 97.0%, 250mg

(5E)-5-(2-hydroxy-3-methoxybenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one, 95.0%, 5g

3-(Trifluoromethyl)benzenesulfonamide>98.0%(HPLC)(T)5g

5-BROMO-2,3-DIHYDRO-1H-INDENE-1-CARBOXYLIC ACID, 95.0%, 250mg

1-(5-Fluoro-3-methyl-benzo[b]thiophen-2-yl)-ethanone, 95.0%, 1g